Medplus promoter Agilemed pledges 5.5 lakh shares to maintain security cover
- Agilemed Investments pledged 5,50,000 shares on September 30, 2026, to maintain security cover for existing NCDs.
- Total promoter group encumbrance rose to 74.10% of their combined shareholding following the new pledge.
- No fresh borrowing occurred; the pledge secures existing debt facilities held by Modulus Alternatives and Neo funds.
- Encumbered shares now constitute 29.79% of Medplus Health Services' total share capital.
*this image is generated using AI for illustrative purposes only.
Medplus Health Services promoter Agilemed Investments Private Limited created a pledge on 5,50,000 equity shares on September 30, 2026. The encumbrance was established in favour of Catalyst Trusteeship Limited, acting as debenture trustee for Modulus Alternatives Investment Managers Limited and Neo debenture holders.
This action was taken solely to maintain the Security Cover Ratio required under existing Share Pledge Agreements. The company clarified that no fresh amount has been borrowed through this transaction. The pledge relates to existing Non-Convertible Debentures (NCDs) issued by Agilemed Investments.
Encumbrance Details and Shareholding Impact
Post the creation of this additional pledge, Agilemed Investments holds an aggregate of 1,34,27,525 equity shares under pledge. This represents 11.18% of the total share capital of Medplus Health Services. The specific breakdown includes 3,00,000 shares pledged against NCDs held by Modulus Alternatives Investment Managers Limited (formerly Centrum Alternative Investment Managers Limited) and 2,50,000 shares pledged against NCDs held by Neo Special Credit Opportunities Fund, Neo Special Credit Opportunities Fund II, Neo Credit Opportunities Fund I, and Neo Markets Services Private Limited.
The underlying debt instruments consist of unlisted, redeemable, unrated NCDs. For the Modulus facility, these are 3,210 NCDs with a nominal value of ₹10,00,000 each. For the Neo facility, these are 1,750 senior secured NCDs with a face value of ₹10,00,000 each, aggregating to ₹175 crore. The Security Cover Ratio for both facilities stands at 2.10.
Promoter Group Encumbrance Status
The pledge by Agilemed is part of a broader pattern of high promoter encumbrance across the promoter group. When combined with encumbrances held by Lone Furrow Investments Private Limited and Madhukar Reddy Gangadi, the total encumbered shares constitute a significant portion of the promoter holding.
| Promoter Entity | Total Holding (%) | Encumbered Shares | Encumbrance % of Total Capital | Encumbered % of Promoter Holding |
|---|---|---|---|---|
| Agilemed Investments Pvt Ltd | 13.03% | 1,34,27,525 | 11.18% | 27.81% |
| Lone Furrow Investments Pvt Ltd | 14.38% | 70,00,000 | 5.83% | 14.50% |
| Madhukar Reddy Gangadi | 12.78% | 1,53,50,400 | 12.78% | 31.79% |
| Total | 40.19% | 3,57,77,925 | 29.79% | 74.10% |
What the Numbers Show
A critical observation from the combined disclosures is the escalating concentration of risk within the promoter group. Following the latest pledge, encumbered shares now account for 74.10% of the total promoter shareholding, up from 72.96% in the previous disclosure. This indicates that nearly three-quarters of the promoter group's wealth is tied up in securing debt facilities.
Furthermore, encumbered shares represent 29.79% of the total share capital of the listed company. Madhukar Reddy Gangadi’s personal holding remains 100% pledged, while Agilemed Investments has seen its encumbered percentage rise to 27.81% of its holding. This high level of collateralization limits the promoters' ability to sell shares or raise further equity without unwinding these pledges, potentially constraining liquidity during market volatility.
Historical Stock Returns for Medplus Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.64% | -1.02% | -4.30% | -22.31% | -14.28% | -42.26% |
How might the 74.10% promoter encumbrance ratio impact Medplus Health Services' ability to raise fresh equity capital for future expansion?
What are the potential market risks if Medplus' share price declines significantly, triggering margin calls on the 29.79% of total capital currently pledged?
Could the high concentration of unrated NCDs among specific alternative investment funds create systemic liquidity risks for the promoter group?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
